Covered recipient · General Payments record
RODNEY B YOUNG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,006.83
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.81 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $174.89 | 11 |
| ABBVIE INC. | $126.01 | 7 |
| Janssen Pharmaceuticals, Inc | $51.98 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.24 | 1 |
| Acerta Pharma LLC | $22.40 | 1 |
| Astellas Pharma US Inc | $21.81 | 1 |
| Lilly USA, LLC | $17.31 | 1 |
| Merck Sharp & Dohme Corporation | $14.78 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.14 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381768 | CMS |
| ABBVIE INC. | $15.61 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381770 | CMS |
| ABBVIE INC. | $13.63 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381772 | CMS |
| ABBVIE INC. | $16.04 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381774 | CMS |
| ABBVIE INC. | $16.55 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381776 | CMS |
| ABBVIE INC. | $29.27 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381778 | CMS |
| ABBVIE INC. | $16.77 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106381780 | CMS |
| Astellas Pharma US Inc | $21.81 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139373909 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.40 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104222295 | CMS |
| Janssen Pharmaceuticals, Inc | $22.53 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078191339 | CMS |
| Janssen Pharmaceuticals, Inc | $29.45 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078191185 | CMS |
| Lilly USA, LLC | $17.31 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387997 | CMS |
| Merck Sharp & Dohme LLC | $14.78 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141579054 | CMS |
| PFIZER INC. | $19.20 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131121948 | CMS |
| PFIZER INC. | $19.76 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131282647 | CMS |
| PFIZER INC. | $16.87 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131228279 | CMS |
| PFIZER INC. | $9.77 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130908989 | CMS |
| PFIZER INC. | $7.36 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130905913 | CMS |
| PFIZER INC. | $16.71 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131646585 | CMS |
| PFIZER INC. | $15.23 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131604549 | CMS |
| PFIZER INC. | $19.31 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131947692 | CMS |
| PFIZER INC. | $15.09 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131255717 | CMS |
| PFIZER INC. | $17.34 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131636236 | CMS |
| PFIZER INC. | $18.25 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131636240 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.24 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137701452 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.39 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144611262 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.